Defining the Optimal Activated Clotting Times During Percutaneous Coronary Intervention: Aggregate Results From 6 Randomized, Controlled Trials

Circulation - United States
doi 10.1161/circ.104.22.e124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal of Clinical Medicine
2020English

How Should a Clinician Interpret Results of Randomized Controlled Trials?: Interpretation of Randomized Controlled Trials

Acta medica Lituanica
2010English

The Economic Burden of Complications During Percutaneous Coronary Intervention

Quality and Safety in Health Care
2007English

Percutaneous Coronary Intervention

2012English

Two Iatrogenic Dissections During Single Percutaneous Coronary Intervention

Cardiologia Croatica
Cardiovascular MedicineCardiology
2013English

Percutaneous Coronary Intervention

2007English

Long-Term Clinical Outcome of Elderly Patients With Acute Coronary Syndrome Treated With Early Percutaneous Coronary Intervention: Insights From the BASE ACS Randomized Controlled Trial

European Journal of Internal Medicine
Internal Medicine
2017English

Percutaneous Coronary Intervention (PCI)

British Journal of Cardiac Nursing
2015English

Balloon Occlusion Types in the Treatment of Coronary Perforation During Percutaneous Coronary Intervention

Cardiology Research and Practice
Cardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy